6Delgado JF, Conde E, Sanchez V, et al. Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure [J]. Eur J Heart Fail, 2005, 7(6) :1011 -1016.
7Radovancevic B, Vrtovec B, Thomas CD, et al. Nitric oxide versus prostaglandin E1 for reduction of pulmonary hypertension in heart transplant candidates[J]. J Heart Lung Transplant, 2005, 24(6) : 690 - 695.
8Kerbaul F, Brimioulle S, Rondelet B, et al. How prostacyclin improves cardiac output in right heart failure in conjunction with pulmonary hypertension[J].Am J Respir Crit Care Med, 2007,175 (8) :846 -850.
9孙衍庆.现代胸心外科学.人民军医出版社,2000,1(1):1273-1280.
10SG. Pu orth IHawmonary vascular disease in different types of congenital Heart disease. Br Heart J, 1984,52:557-571.
6Taylor J.The 2010 version of the ESC guidelines for the management of grown-up adult congenital heart disease are discussed by guidelines task force chairman H.Baumgartner [ J ].Eur Heart J, 2010,31 (23) : 2 825-2 826.
7Koyak Z,Harris L,de Groot JR,et al.Sudden cardiac death in adult congenital heart disease [ J ].Circulation, 2012,126 (16) : 1944-54.
9Amaral FT, Rodrigues A J, Manso PH, et al.Adult congenital heart dis- ease : experience with the surgical approach [J ] .Rev Bras Cir Cardio- vasc ,2013,28 (3) :371-379.
10Maxwell BG, Wong JK, Kin C, et al.2013.Perioperative outcomes of ma- jor noncardiac surgery in adults with congenital heart disease [J].Anes- thesiology, 2013,119 ( 4 ) : 762-729.
